Home175250 • KOSDAQ
add
Icure Pharmaceutical Inc
Previous close
₩2,170.00
Year range
₩1,399.00 - ₩2,350.00
Market cap
81.50B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 25.14B | 59.79% |
Operating expense | 4.14B | -38.09% |
Net income | -3.70B | -116.71% |
Net profit margin | -14.73 | -110.46% |
Earnings per share | — | — |
EBITDA | -1.35B | 40.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.19B | -81.36% |
Total assets | 120.88B | -14.68% |
Total liabilities | 73.39B | 15.93% |
Total equity | 47.49B | — |
Shares outstanding | 37.39M | — |
Price to book | 1.76 | — |
Return on assets | -6.22% | — |
Return on capital | -8.59% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.70B | -116.71% |
Cash from operations | -2.99B | 57.56% |
Cash from investing | -15.19B | -127.87% |
Cash from financing | 12.32B | 131.72% |
Net change in cash | -5.87B | -168.04% |
Free cash flow | -7.25B | -132.16% |
About
Founded
2000
Website
Employees
210
